BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.640
-0.010 (-0.38%)
Mar 9, 2026, 4:00 PM EDT - Market closed
BioLineRx Revenue
BioLineRx had revenue of $427.00K in the quarter ending September 30, 2025, a decrease of -91.36%. This brings the company's revenue in the last twelve months to $12.74M, down -42.09% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$12.74M
Revenue Growth
-42.09%
P/S Ratio
0.93
Revenue / Employee
$454,821
Employees
28
Market Cap
11.78M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curis | 11.65M |
| BioAtla | 11.00M |
| Traws Pharma | 2.85M |
| CytoMed Therapeutics | 573.19K |
| BioCardia | 3.00K |
| Soligenix | 2.34K |
BLRX News
- 3 months ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 3 months ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 3 months ago - BioLineRx GAAP EPS of $0.00 beats by $0.54, revenue of $0.43M misses by $0.24M - Seeking Alpha
- 3 months ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 3 months ago - BioLine Rx's Earnings: A Preview - Benzinga
- 3 months ago - BioLineRx Q3 2025 Earnings Preview - Seeking Alpha